Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_provenance.
- NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_assertion description "[Therefore, the SEA D227A-Mx3 diabody is considered to be a promising reagent in specific targeted immunotherapy for BDC and other MUC1-positive carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_provenance.
- NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_assertion evidence source_evidence_literature NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_provenance.
- NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_assertion SIO_000772 11845258 NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_provenance.
- NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_assertion wasDerivedFrom befree-20140225 NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_provenance.
- NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_assertion wasGeneratedBy ECO_0000203 NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_provenance.
- befree-20140225 importedOn "2014-02-25" NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_provenance.